Aries Wealth Management
VRTX icon

Aries Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Aries Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$316K Hold
605
– – 0.06% 192
2026
Q2 		$301K Hold
605
– – 0.06% 200
2026
Q1 		$270K Hold
605
– – 0.06% 197
2025
Q4 		$274K Hold
605
– – 0.06% 193
2025
Q3 		$237K Hold
605
– – 0.06% 207
2025
Q2 		$269K Hold
605
– – 0.07% 193
2025
Q1 		$293K Buy
+605
New +$282K 0.08% 183
2024
Q4 		– Sell
-475
Closed -$221K – 235
2024
Q3 		$221K Hold
475
– – 0.06% 211
2024
Q2 		$223K Buy
+475
New +$206K 0.07% 189

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Provident Investment Management
Provident Investment Management Novi, Michigan $999M AUM 19.45% 1-Year Est. Return

Aries Wealth Management's VRTX Position: Q3 2026 in Review

Aries Wealth Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 605 shares worth $316K. The position accounts for 0.06% of the portfolio, ranked #192.

Aries Wealth Management first reported a position in VRTX in Q2 2024 and has held it in 9 quarters since. 478 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Aries Wealth Management held 605 shares of Vertex Pharmaceuticals worth $316K as of Q3 2026.
  • Aries Wealth Management left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.06% of Aries Wealth Management's portfolio in Q3 2026, its #192 holding.
  • Aries Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 478 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Aries Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.